Mission Therapeutics to Participate in the Solebury Trout Fall Private Company Showcase 2021

CAMBRIDGE, England–(BUSINESS WIRE)–Mission Therapeutics (“Mission”), a drug discovery and development company focused on selectively inhibiting deubiquitylating enzymes (DUBs), today announced that its CEO, Anker Lundemose, will attend and present at the 8^th Annual Solebury Trout…